Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Results from the VISION study and local UK experience Meeting Abstract


Authors: Cui, W.; Brown, N.; Brown, V.; Bulusu, R.; Denton, A.; Evans, J.; Forster, M.; Papadatos-Pastos, D.; Pellegrino, L.; Walsh, N.; Bruns, R.; Otto, G.; Paik, P.
Abstract Title: Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Results from the VISION study and local UK experience
Meeting Title: 20th Annual Conference of the British Thoracic Oncology Group (BTOG)
Journal Title: Lung Cancer
Volume: 165
Issue: Suppl. 1
Meeting Dates: 2022 Jan 27-28
Meeting Location: Virtual
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2022-03-01
Start Page: S38
End Page: S39
Language: English
ACCESSION: WOS:000774314500082
PROVIDER: wos
DOI: 10.1016/S0169-5002(22)00128-3
Notes: Meeting Abstract: 81 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik